Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Site revision updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-21T00:31:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:36:13.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-02-20T15:09:51.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page; the related topics 'Multiple myeloma' and 'MedlinePlus Genetics' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T07:52:52.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.1 has been added and Revision: v3.4.0 has been removed from the page's documents section.
    Difference
    0.1%
    Check dated 2026-02-05T18:57:05.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Related topics were added to the page, including Multiple Myeloma and MedlinePlus Genetics. The page revision was updated from v3.3.3 to v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-15T03:05:05.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.